The Race to prevent and treat Respiratory Syncytial Virus (RSV) is on.
As the respiratory illness affects children globally at an alarming rate, researchers are working hard to find preventative measures and treatments to slow the trend. We conducted a search in Dr.Evidence’s DocSearch platform to gain some visibility and insights.
Published Literature
Published literature on the topic has steadily increased over the past 10 years, from 364 publications in 2012 to over 1,000 in 2021 and almost 800 in 2022 year-to-date.
Clinical Trials
Clinical Trial Geography
The 85 active or recruiting clinical trials are being held across 54 countries, with the highest number of trials occurring in the US, UK, Spain, South Africa and Finland.
Outcomes of interest
Out of 348 Publications citing real-world evidence in 2022, 69% referenced hospitalization, among other serious outcomes.
